American Vanguard (NYSE:AVD – Get Free Report) announced its quarterly earnings results on Wednesday. The basic materials company reported ($0.14) EPS for the quarter, missing the consensus estimate of ($0.06) by ($0.08), Zacks reports. American Vanguard had a negative net margin of 8.71% and a negative return on equity of 4.00%. The firm had revenue of $123.57 million during the quarter, compared to the consensus estimate of $120.00 million.
Here are the key takeaways from American Vanguard’s conference call:
- Net sales were $124 million, up ~7% YoY—driven by a 17% increase in U.S. crop sales and 6% specialty growth, while international sales declined ~7% due to timing in Brazil and India.
- Adjusted EBITDA surged ~245% YoY to $10.3 million and gross margin improved ~500 bps; management reiterates 2026 guidance of $44–$48 million adjusted EBITDA on $530–$550 million sales.
- Operational moves—shifting synthesis from the L.A. site to Axis, Alabama—are expected to drive at least $4 million in annualized savings, contributed to lower adjusted operating expenses (26.7% of sales) and a $10 million inventory reduction YoY.
- The new capital structure replaced the revolver with term loans, raising cash to $71 million but increasing total debt to $267 million (net debt ~$196 million); management warns the refinancing is higher cost even though it provides liquidity and flexibility.
- Growth strategy and targets include 50 new product launches in five years to add $100 million annualized revenue by 2030, a goal of >$600 million revenue by end-2028, and a long-term ~15% EBITDA margin target.
American Vanguard Price Performance
Shares of American Vanguard stock traded up $0.08 on Thursday, hitting $2.99. 430,230 shares of the company traded hands, compared to its average volume of 246,173. The firm’s 50-day simple moving average is $3.14 and its 200 day simple moving average is $4.08. The company has a current ratio of 1.77, a quick ratio of 0.93 and a debt-to-equity ratio of 0.90. The company has a market cap of $102.21 million, a P/E ratio of -1.88 and a beta of 1.48. American Vanguard has a 12-month low of $2.05 and a 12-month high of $5.92.
Institutional Trading of American Vanguard
Wall Street Analyst Weigh In
Separately, Weiss Ratings raised shares of American Vanguard from a “sell (e+)” rating to a “sell (d-)” rating in a report on Monday. One analyst has rated the stock with a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $12.00.
American Vanguard Company Profile
American Vanguard Corporation (NYSE: AVD) is a developer, manufacturer and marketer of specialty chemical products for crop protection, turf and ornamental care, and public health pest control. Headquartered in Newport Beach, California, the company offers a portfolio of insecticides, herbicides, fungicides and rodenticides designed for use across agricultural, turf and urban pest management applications. Its research and development efforts focus on novel chemistries and formulation technologies that address emerging pest resistance and regulatory requirements.
The company’s product lines include emulsifiable concentrates, wettable powders, granular formulations, baits and liquid concentrates sold under proprietary brand names.
Featured Stories
Receive News & Ratings for American Vanguard Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Vanguard and related companies with MarketBeat.com's FREE daily email newsletter.
